{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:29:01Z","timestamp":1792290541253,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    YTH\n                    <jats:italic>N<\/jats:italic>\n                    <jats:sup>6<\/jats:sup>\n                    -methyladenosine RNA binding protein F1 (YTHDF1) enables\n                    <jats:italic>N<\/jats:italic>\n                    <jats:sup>6<\/jats:sup>\n                    -methyladenosine-containing RNA binding activity, involved in mRNA destabilization and positive regulation of translational initiation. Here we aimed to investigate the main molecular events associated with YTHDF1 during the course of metabolic dysfunction-associated steatotic liver disease (MASLD). YTHDF1 expression was detected by western blotting and real-time PCR.\n                    <jats:italic>Ythdf1<\/jats:italic>\n                    hepatocyte-specific knockout mice were generated in this study. RNA sequencing and proteomic analyses were performed to investigate potentially involved molecular pathways. The protein levels of YTHDF1 were increased during MASLD progression. Under high-fat diet intervention, hepatocyte-specific\n                    <jats:italic>Ythdf1<\/jats:italic>\n                    -knockout mice exhibited a pronounced increase in both liver weight and liver-to-body weight ratio, accompanied by significant hepatic steatosis. YTHDF1 depletion promotes the progression of MASLD through enhanced peroxisome activation and mitochondria dysfunction, which are independent of its RNA\n                    <jats:italic>N<\/jats:italic>\n                    <jats:sup>6<\/jats:sup>\n                    -methyladenosine reader activity. In particular, decreased YTHDF1 enhances the expression of acyl-CoA oxidase 1 (ACOX1), and peroxisome activation in a manner relies on YTHDF1 facilitating the formation of stress granules in MASLD. In addition, YTHDF1 was localized in the mitochondria and interacted with SLC25A11, affecting mitochondrial glutathione transport and its homeostasis. Finally, the identified lysine 191 methylation modification can reduce the stability of YTHDF1 protein, thereby achieving its protein expression regulation during MASLD progression. YTHDF1 inhibits MASLD progression by modulating stress granule sequestration of\n                    <jats:italic>ACOX1<\/jats:italic>\n                    mRNA and maintaining mitochondrial homeostasis.\n                  <\/jats:p>","DOI":"10.1038\/s12276-026-01686-3","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:23:21Z","timestamp":1775813001000},"page":"1172-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Noncanonical function of epigenetic reader YTHDF1 inhibits MASLD progression by maintaining peroxisomes and mitochondrial homeostasis"],"prefix":"10.1038","volume":"58","author":[{"given":"Chenyang","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-9198","authenticated-orcid":false,"given":"Yuefan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2459-3923","authenticated-orcid":false,"given":"Fu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"1686_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong, V. W., Ekstedt, M., Wong, G. L. & Hagstr\u00f6m, H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79, 842\u2013852 (2023).","journal-title":"J. Hepatol."},{"key":"1686_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3350\/cmh.2024.0109","volume":"30","author":"H Crane","year":"2024","unstructured":"Crane, H. et al. Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Clin. Mol. Hepatol. 30, 436\u2013448 (2024).","journal-title":"Clin. Mol. Hepatol."},{"key":"1686_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3350\/cmh.2024.0145","volume":"30","author":"S Jeong","year":"2024","unstructured":"Jeong, S. et al. Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: a nationwide cohort study. Clin. Mol. Hepatol. 30, 487\u2013499 (2024).","journal-title":"Clin. Mol. Hepatol."},{"key":"1686_CR4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","volume":"9","author":"H Hagstrom","year":"2024","unstructured":"Hagstrom, H., Shang, Y., Hegmar, H. & Nasr, P. Natural history and progression of metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol. Hepatol. 9, 944\u2013956 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1686_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156015","volume":"161","author":"T Lan","year":"2024","unstructured":"Lan, T. & Tacke, F. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies. Metabolism 161, 156015 (2024).","journal-title":"Metabolism"},{"key":"1686_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.20517\/2394-5079.2021.136","volume":"8","author":"E Desjonqueres","year":"2022","unstructured":"Desjonqueres, E. & Gigante, E. Hepatocellular carcinoma on the background of nonalcoholic fatty liver disease: epidemiological update. Hepatoma Res. 8, 16 (2022).","journal-title":"Hepatoma Res."},{"key":"1686_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"N Stefan","year":"2019","unstructured":"Stefan, N., H\u00e4ring, H. U. & Cusi, K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 7, 313\u2013324 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1686_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct. Target. Ther. 7, 287 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1686_CR9","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen, D. H., Lykkesfeldt, J. & Tveden-Nyborg, P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell. Mol. Life Sci. 75, 3313\u20133327 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"1686_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/15548627.2023.2254191","volume":"20","author":"Q Ren","year":"2024","unstructured":"Ren, Q., Sun, Q. & Fu, J. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease. Autophagy 20, 221\u2013241 (2024).","journal-title":"Autophagy"},{"key":"1686_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13622","volume":"52","author":"A Karkucinska-Wieckowska","year":"2022","unstructured":"Karkucinska-Wieckowska, A. et al. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship. Eur. J. Clin. Invest. 52, e13622 (2022).","journal-title":"Eur. J. Clin. Invest."},{"key":"1686_CR12","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1096\/fj.201801498R","volume":"33","author":"S Violante","year":"2019","unstructured":"Violante, S. et al. Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4. FASEB J. 33, 4355\u20134364 (2019).","journal-title":"FASEB J."},{"key":"1686_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2020.05.007","volume":"79","author":"A He","year":"2020","unstructured":"He, A. et al. Acetyl-CoA derived from hepatic peroxisomal \u03b2-oxidation inhibits autophagy and promotes steatosis via mTORC1 activation. Mol. Cell 79, 30\u201342 (2020).","journal-title":"Mol. Cell"},{"key":"1686_CR14","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","volume":"3","author":"L Ding","year":"2021","unstructured":"Ding, L. et al. Peroxisomal \u03b2-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis. Nat. Metab. 3, 1648\u20131661 (2021).","journal-title":"Nat. Metab."},{"key":"1686_CR15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","volume":"19","author":"P Farzanegi","year":"2019","unstructured":"Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M. & Azarbayjani, M. A. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur. J. Sport Sci. 19, 994\u20131003 (2019).","journal-title":"Eur. J. Sport Sci."},{"key":"1686_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tcb.2016.05.004","volume":"26","author":"DSW Protter","year":"2016","unstructured":"Protter, D. S. W. & Parker, R. Principles and properties of stress granules. Trends Cell Biol. 26, 668\u2013679 (2016).","journal-title":"Trends Cell Biol."},{"key":"1686_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105143","volume":"161","author":"F Wang","year":"2020","unstructured":"Wang, F., Li, J., Fan, S., Jin, Z. & Huang, C. Targeting stress granules: a novel therapeutic strategy for human diseases. Pharmacol. Res. 161, 105143 (2020).","journal-title":"Pharmacol. Res."},{"key":"1686_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/0008-5472.CAN-23-1916","volume":"84","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. N6-methyladenosine reader YTHDF1 promotes stemness and therapeutic resistance in hepatocellular carcinoma by enhancing NOTCH1 expression. Cancer Res. 84, 827\u2013840 (2024).","journal-title":"Cancer Res."},{"key":"1686_CR19","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949229","volume":"21","author":"B Han","year":"2020","unstructured":"Han, B. et al. YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness. EMBO Rep. 21, e49229 (2020).","journal-title":"EMBO Rep."},{"key":"1686_CR20","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.7150\/thno.73746","volume":"12","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming. Theranostics 12, 4802\u20134817 (2022).","journal-title":"Theranostics"},{"key":"1686_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35710-7","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin, W. et al. Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat. Commun. 14, 265 (2023).","journal-title":"Nat. Commun."},{"key":"1686_CR22","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388\u20131399 (2015).","journal-title":"Cell"},{"key":"1686_CR23","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara, S. & Jaffrey, S. R. A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA. Cell 181, 1582\u20131595 (2020).","journal-title":"Cell"},{"key":"1686_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","volume":"9","author":"YF Wang","year":"2024","unstructured":"Wang, Y. F. et al. METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression. Signal Transduct. Target. Ther. 9, 91 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1686_CR25","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","volume":"79","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. J. Hepatol. 79, 1185\u20131200 (2023).","journal-title":"J. Hepatol."},{"key":"1686_CR26","doi-asserted-by":"publisher","first-page":"e00466","DOI":"10.14309\/ctg.0000000000000466","volume":"13","author":"P Pettinelli","year":"2022","unstructured":"Pettinelli, P. et al. Relationship between hepatic gene expression, intestinal microbiota, and inferred functional metagenomic analysis in NAFLD. Clin. Transl. Gastroenterol. 13, e00466 (2022).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"1686_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102021","volume":"45","author":"S Jang","year":"2021","unstructured":"Jang, S. et al. Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytes. Redox Biol. 45, 102021 (2021).","journal-title":"Redox Biol."},{"key":"1686_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cbi.2006.03.001","volume":"163","author":"LH Lash","year":"2006","unstructured":"Lash, L. H. Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem. Biol. Interact. 163, 54\u201367 (2006).","journal-title":"Chem. Biol. Interact."},{"key":"1686_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/hep.32112","volume":"75","author":"CD Fuchs","year":"2022","unstructured":"Fuchs, C. D. et al. Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase\/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice. Hepatology 75, 125\u2013139 (2022).","journal-title":"Hepatology"},{"key":"1686_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jhep.2010.07.039","volume":"54","author":"H Miyoshi","year":"2011","unstructured":"Miyoshi, H. et al. Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J. Hepatol. 54, 432\u2013438 (2011).","journal-title":"J. Hepatol."},{"key":"1686_CR31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/HYPERTENSIONAHA.114.04094","volume":"64","author":"H Weng","year":"2014","unstructured":"Weng, H., Ji, X., Endo, K. & Iwai, N. Pex11a deficiency is associated with a reduced abundance of functional peroxisomes and aggravated renal interstitial lesions. Hypertension 64, 1054\u20131060 (2014).","journal-title":"Hypertension"},{"key":"1686_CR32","doi-asserted-by":"publisher","first-page":"104501","DOI":"10.1016\/j.dci.2022.104501","volume":"136","author":"A Kong","year":"2022","unstructured":"Kong, A. et al. Role of acyl-coenzyme A oxidase 1 (ACOX1) on palmitate-induced inflammation and ROS production of macrophages in large yellow croaker (Larimichthys crocea). Dev. Comp. Immunol. 136, 104501 (2022).","journal-title":"Dev. Comp. Immunol."},{"key":"1686_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102921","volume":"67","author":"W Yang","year":"2023","unstructured":"Yang, W. et al. YTHDF1 mitigates acute kidney injury via safeguarding m6A-methylated mRNAs in stress granules of renal tubules. Redox Biol. 67, 102921 (2023).","journal-title":"Redox Biol."},{"key":"1686_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66837-6","volume":"10","author":"G Pan","year":"2020","unstructured":"Pan, G. et al. SLC25A11 serves as a novel prognostic biomarker in liver cancer. Sci. Rep. 10, 9871 (2020).","journal-title":"Sci. Rep."},{"key":"1686_CR35","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.7150\/thno.63824","volume":"12","author":"L Xu","year":"2022","unstructured":"Xu, L. et al. Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1\u03b1. Theranostics 12, 2502\u20132518 (2022).","journal-title":"Theranostics"},{"key":"1686_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03591-1","volume":"12","author":"T Guo","year":"2021","unstructured":"Guo, T. et al. S-adenosylmethionine upregulates the angiotensin receptor-binding protein ATRAP via the methylation of HuR in NAFLD. Cell Death Dis. 12, 306 (2021).","journal-title":"Cell Death Dis."},{"key":"1686_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","volume":"6","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct. Target. Ther. 6, 76 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1686_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cmet.2014.01.002","volume":"19","author":"IJ Lodhi","year":"2014","unstructured":"Lodhi, I. J. & Semenkovich, C. F. Peroxisomes: a nexus for lipid metabolism and cellular signaling. Cell Metab. 19, 380\u2013392 (2014).","journal-title":"Cell Metab."},{"key":"1686_CR39","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"1686_CR40","doi-asserted-by":"publisher","first-page":"31011","DOI":"10.1074\/jbc.M110.127159","volume":"285","author":"D Hall","year":"2010","unstructured":"Hall, D. et al. Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state. J. Biol. Chem. 285, 31011\u201331023 (2010).","journal-title":"J. Biol. Chem."},{"key":"1686_CR41","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","volume":"1863","author":"HR Waterham","year":"2016","unstructured":"Waterham, H. R., Ferdinandusse, S. & Wanders, R. J. A. Human disorders of peroxisome metabolism and biogenesis. Biochi. Biophys. Acta Mol. Cell Res. 1863, 922\u2013933 (2016).","journal-title":"Biochi. Biophys. Acta Mol. Cell Res."},{"key":"1686_CR42","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.7150\/ijbs.84768","volume":"19","author":"M-Y Ke","year":"2023","unstructured":"Ke, M.-Y. et al. The m6A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m6A dependent manner. Int. J. Biol. Sci. 19, 3987\u20134003 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"1686_CR43","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1016\/j.cell.2023.07.013","volume":"186","author":"Y Geffen","year":"2023","unstructured":"Geffen, Y. et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186, 3945\u20133967 (2023).","journal-title":"Cell"},{"key":"1686_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27175-x","volume":"13","author":"CA Berryhill","year":"2023","unstructured":"Berryhill, C. A. et al. Global lysine methylome profiling using systematically characterized affinity reagents. Sci. Rep. 13, 377 (2023).","journal-title":"Sci. Rep."},{"key":"1686_CR45","doi-asserted-by":"publisher","first-page":"16618","DOI":"10.1021\/acs.analchem.1c04031","volume":"93","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Highly efficient enrichment of O-GlcNAc glycopeptides based on chemical oxidation and reversible hydrazide chemistry. Anal. Chem. 93, 16618\u201316627 (2021).","journal-title":"Anal. Chem."},{"key":"1686_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104738","volume":"299","author":"J Li","year":"2023","unstructured":"Li, J. et al. O-GlcNAcylation promotes the cytosolic localization of the m6A reader YTHDF1 and colorectal cancer tumorigenesis. J. Biol. Chem. 299, 104738 (2023).","journal-title":"J. Biol. Chem."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01686-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:05:55Z","timestamp":1782716755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01686-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1686"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01686-3","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}